- 全部删除
您的购物车当前为空
Imrecoxib (BAP-909) 是 COX1和 COX2的抑制剂,IC50值为 115 和 18 nM,具有抗炎作用。

Imrecoxib (BAP-909) 是 COX1和 COX2的抑制剂,IC50值为 115 和 18 nM,具有抗炎作用。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 233 | In stock | |
| 50 mg | 待询 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 363 | In stock |
Imrecoxib 相关产品
| 产品描述 | Imrecoxib (BAP-909) is a novel and selective cyclooxygenase 2 (COX-2) inhibitor (IC50: 18 nM). It also inhibits COX1- activity (IC50: 115 nM). Imrecoxib has an anti-inflammatory effect. |
| 靶点活性 | COX-2(human):18 nM, COX-1:115 nM, COX-2:115 nM |
| 体外活性 | In U937 cells, Imrecoxib (0.1-10 μM; 24 hours) reduces COX-2 mRNA level induced by PMA+LPS in a dose-dependent manner. |
| 体内活性 | Imrecoxib (gastrointestinal administration; 5-20 mg/kg; started on day 7; 26 days) diminishes the secondary paw swelling. It also inhibits heat-inactivated BCG induced-inflammtory polyarthritis. Imrecoxib (gastrointestinal administration; 5-20 mg/kg; 1 hour before carrageenan injection) suppresses carrageenan-induced acute inflammation, and the inhibitory effect is maximal at 4 hours. |
| 别名 | 艾瑞昔布, BAP-909 |
| 分子量 | 369.48 |
| 分子式 | C21H23NO3S |
| CAS No. | 395683-14-4 |
| Smiles | CCCN1CC(=C(C1=O)c1ccc(C)cc1)c1ccc(cc1)S(C)(=O)=O |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 90 mg/mL (243.59 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容